[{"data":1,"prerenderedAt":66},["ShallowReactive",2],{"q-nurse-110-1-basic-medicine-057":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":36,"lastmod":65},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":27},"nurse-110-1-基礎醫學-057","nurse-110-1-basic-medicine-057",110,1,57,"下列何種安眠藥物被濫用的可能性較低，而未被列為管制藥品？",{"A":15,"B":16,"C":17,"D":18},"Zolpidem","Zaleplon","Eszopiclone","Ramelteon","D",null,[],"本題考點是各類安眠藥的濫用潛勢與管制分類。依藥理學,Ramelteon 是選擇性褪黑激素受體(MT1、MT2)促效劑,不作用於 GABA 系統,幾乎無成癮性與濫用潛勢,故未被列為管制藥品,選 D。考點在於區分作用機轉決定的濫用風險:A Zolpidem、B Zaleplon、C Eszopiclone 皆為作用於 GABA-A 受體的非苯二氮平類(Z-drugs),具依賴與濫用可能,故被列為管制藥品,三者皆非答案,唯 Ramelteon 因機轉不同而濫用潛勢最低。","安眠藥的成癮風險與是否強化 GABA 抑制息息相關:凡作用於 GABA-A 的苯二氮平類與 Z-drugs 都可能耐受、依賴與反彈性失眠;Ramelteon 走褪黑激素路徑,調整生理時鐘而不抑制中樞,故安全性高、不列管。另一非管制助眠選項 doxepin(低劑量抗組織胺)機轉亦不同。記憶法:名字帶 mel\u002F褪黑激素路徑者,濫用潛勢低。",[25,28,31,32,34],{"term":26,"count":27},"GABA-A 受體",5,{"term":29,"count":30},"褪黑激素受體促效劑",2,{"term":18,"count":11},{"term":33,"count":11},"Z-drugs",{"term":35,"count":11},"管制藥品",[37,41,45,50,55,60],{"webId":38,"stem":39,"number":40,"year":10,"session":11},"nurse-110-1-basic-medicine-058","Alteplase 主要用於治療急性缺血性中風、心肌梗塞、肺栓塞、深部靜脈栓塞，其藥理作用機轉為何？",58,{"webId":42,"stem":43,"number":44,"year":10,"session":30},"nurse-110-2-basic-medicine-074","關於肉毒梭孢桿菌（Clostridium botulinum）感染之敘述，下列何者錯誤？",74,{"webId":46,"stem":47,"number":48,"year":49,"session":30},"nurse-111-2-basic-medicine-008","鼠蹊部疝氣（inguinal hernia）嚴重時，擠入鼠蹊管（inguinal canal）的腸子，最容易直接壓迫到下列何者，造成睪丸的血液循環受阻？",8,111,{"webId":51,"stem":52,"number":53,"year":54,"session":11},"nurse-113-1-basic-medicine-006","科林菲特氏症（Klinefelter's syndrome）患者的白血球細胞核旁，最多可以看到幾個巴氏體（barr body）？",6,113,{"webId":56,"stem":57,"number":58,"year":59,"session":30},"nurse-114-2-basic-medicine-010","下列何者攜帶的神經纖維刺激耳下腺的分泌？",10,114,{"webId":61,"stem":62,"number":63,"year":64,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,106,"2026-09-04",1788510719633]